About:
About AccessDX Laboratory
AccessDX Laboratory is a CLIA-certified, CAP-accredited and NYCQ diagnostic laboratory dedicated to providing clinical insights that improve patient outcomes. AccessDX diagnostic solutions include COVID-19 testing, pharmacogenomic (PGX) testing, cancer genomic (CGX) testing, respiratory pathogen panels and a wide range of other clinical laboratory services. AccessDX diagnostic and software solutions are currently trusted by thousands of clinical providers in health systems nationwide.

About MedTek21
MedTek21 is a real-time population health and medication risk management platform that brings personalized drug-to-gene monitoring to every patient. The company’s software-based platform works alongside existing medical record systems to continuously monitor, proactively identify, and help remediate potential medication risks. MedTek21’s mobile-based medication risk alerting, drug lookup tools, actionable reporting, and clinical support staff enable both patients and their care providers with better real-time decision making. MedTek21 is being used to positively impact outcomes and lower care costs for tens of thousands of patients across general, acute, and chronic populations.


About 2bPrecise
The 2bPrecise platform consumes genetic/genomic data from molecular labs and clinical information from EHRs, synthesizing them into a clinical-genomic ontology. It brings the resulting precision medicine insights into a physician’s EHR workflow for immediate and timely use. With discrete test results consolidated into an invaluable data set, provider organizations are equipped to drive efficient workflows for genomic workflows and decision-making, extract population analytics, design clinical intervention programs, build cohorts for trial recruitment, enable participation in research studies and more.

Back to HCB News

Business Affairs Homepage